Proton pump inhibitor side effects and drug interactions: much ado about nothing?
- PMID: 21199906
- DOI: 10.3949/ccjm.77a.10087
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Abstract
Proton pump inhibitors (PPIs) are widely prescribed for acid-peptic disease. In general, the safety of this class of drugs has been excellent. However, in the past several years, epidemiologic studies have indicated possible risks that are biologically plausible.
Comment in
-
Coadministration of clopidogrel and proton pump inhibitors.Cleve Clin J Med. 2011 May;78(5):284; author reply 284-5. doi: 10.3949/ccjm.78c.05001. Cleve Clin J Med. 2011. PMID: 21688684 No abstract available.
Similar articles
-
Long-term safety concerns with proton pump inhibitors.Am J Med. 2009 Oct;122(10):896-903. doi: 10.1016/j.amjmed.2009.04.014. Am J Med. 2009. PMID: 19786155 Review.
-
PPI interactions with clopidogrel.Med Lett Drugs Ther. 2009 Jan 12;51(1303):2-3. Med Lett Drugs Ther. 2009. PMID: 19122567 Review.
-
Proton pump inhibitor use and enteric infections.Am J Gastroenterol. 2009 Mar;104 Suppl 2:S10-6. doi: 10.1038/ajg.2009.46. Am J Gastroenterol. 2009. PMID: 19262540 Review.
-
What are the precautions with proton pump inhibitor use for reflux disease?JAAPA. 2015 Dec;28(12):23-6. doi: 10.1097/01.JAA.0000473372.47749.16. JAAPA. 2015. PMID: 26595692
-
Gastroesophageal reflux disease.N Engl J Med. 2009 Feb 12;360(7):729; author reply 729-30. doi: 10.1056/NEJMc082292. N Engl J Med. 2009. PMID: 19213690 No abstract available.
Cited by
-
Incidence of postoperative dyspepsia is not associated with prophylactic use of drugs.Sao Paulo Med J. 2014;132(4):219-23. doi: 10.1590/1516-3180.2014.1324676. Sao Paulo Med J. 2014. PMID: 25055067 Free PMC article.
-
Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.PLoS One. 2017 Jan 19;12(1):e0169826. doi: 10.1371/journal.pone.0169826. eCollection 2017. PLoS One. 2017. PMID: 28103324 Free PMC article.
-
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.Sci Rep. 2017 Jun 6;7(1):2871. doi: 10.1038/s41598-017-03069-1. Sci Rep. 2017. PMID: 28588208 Free PMC article.
-
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3. Circulation. 2013. PMID: 23825361 Free PMC article.
-
The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Osteoporos Int. 2013 Nov;24(11):2737-48. doi: 10.1007/s00198-013-2335-4. Epub 2013 Mar 28. Osteoporos Int. 2013. PMID: 23536255 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous